Insider Transactions in Q4 2021 at Cumberland Pharmaceuticals Inc (CPIX)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 08
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.23%
|
$84
$2.95 P/Share
|
Nov 05
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.71 P/Share
|
Nov 05
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
85
+0.05%
|
$170
$2.71 P/Share
|
Nov 05
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.71 P/Share
|
Nov 05
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.11%
|
$30
$2.71 P/Share
|
Nov 05
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.23%
|
$84
$2.71 P/Share
|
Nov 04
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.73 P/Share
|
Nov 04
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
85
+0.05%
|
$170
$2.76 P/Share
|
Nov 04
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.73 P/Share
|
Nov 04
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.11%
|
$30
$2.73 P/Share
|
Nov 04
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.23%
|
$84
$2.73 P/Share
|
Nov 03
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.71 P/Share
|
Nov 03
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
85
+0.05%
|
$170
$2.71 P/Share
|
Nov 03
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.71 P/Share
|
Nov 03
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.11%
|
$30
$2.71 P/Share
|
Nov 03
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.23%
|
$84
$2.71 P/Share
|
Nov 02
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.63 P/Share
|
Nov 02
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
85
+0.05%
|
$170
$2.63 P/Share
|
Nov 02
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.63 P/Share
|
Nov 02
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.11%
|
$30
$2.63 P/Share
|
Nov 02
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.23%
|
$84
$2.63 P/Share
|
Nov 02
2021
|
Joseph C Galante |
BUY
Open market or private purchase
|
Direct |
142
+0.32%
|
$284
$2.63 P/Share
|
Nov 01
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.67 P/Share
|
Nov 01
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
85
+0.05%
|
$170
$2.67 P/Share
|
Nov 01
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.67 P/Share
|
Nov 01
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.11%
|
$30
$2.67 P/Share
|
Nov 01
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.23%
|
$84
$2.67 P/Share
|
Nov 01
2021
|
Joseph C Galante |
BUY
Open market or private purchase
|
Direct |
142
+0.32%
|
$284
$2.67 P/Share
|
Oct 29
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.72 P/Share
|
Oct 29
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
85
+0.05%
|
$170
$2.72 P/Share
|
Oct 29
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.72 P/Share
|
Oct 29
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.23%
|
$84
$2.72 P/Share
|
Oct 29
2021
|
Joseph C Galante |
BUY
Open market or private purchase
|
Direct |
142
+0.32%
|
$284
$2.72 P/Share
|
Oct 29
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.11%
|
$30
$2.72 P/Share
|
Oct 28
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.61 P/Share
|
Oct 28
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
85
+0.05%
|
$170
$2.61 P/Share
|
Oct 28
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.61 P/Share
|
Oct 28
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.23%
|
$84
$2.61 P/Share
|
Oct 28
2021
|
Joseph C Galante |
BUY
Open market or private purchase
|
Direct |
142
+0.32%
|
$284
$2.61 P/Share
|
Oct 28
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.11%
|
$30
$2.61 P/Share
|
Oct 27
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.61 P/Share
|
Oct 27
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
85
+0.05%
|
$170
$2.61 P/Share
|
Oct 27
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.61 P/Share
|
Oct 27
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.23%
|
$84
$2.61 P/Share
|
Oct 27
2021
|
Joseph C Galante |
BUY
Open market or private purchase
|
Direct |
142
+0.33%
|
$284
$2.61 P/Share
|
Oct 27
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.11%
|
$30
$2.61 P/Share
|
Oct 26
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.06%
|
$210
$2.64 P/Share
|
Oct 26
2021
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
85
+0.05%
|
$170
$2.64 P/Share
|
Oct 26
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.64 P/Share
|
Oct 26
2021
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
42
+0.23%
|
$84
$2.64 P/Share
|